Irish company Neuromod has raised €5.5 million to fund clinical trials in the US for a device that targets millions of people suffering from chronic tinnitus. Tinnitus, often described as
Irish company Neuromod has raised €5.5 million to fund clinical trials in the US for a device that targets millions of people suffering from chronic tinnitus. Tinnitus, often described as